[The new oral anticoagulant in the Netherlands].
Leebeek
Frank W G
FW
Erasmus MC-Centrum, Rotterdam, afd. Hematologie, Rotterdam. f.leebeek@erasmusmc.nl
Kamphuisen
Pieter Willem
PW
D000284:Administration, Oral; D000925:Anticoagulants / Q000008:administration & dosage* / Q000493:pharmacokinetics; D001562:Benzimidazoles / Q000008:administration & dosage* / Q000493:pharmacokinetics; D000069604:Dabigatran; D004347:Drug Interactions; D017558:Elective Surgical Procedures; D006801:Humans; D009025:Morpholines / Q000008:administration & dosage* / Q000493:pharmacokinetics; D009426:Netherlands; D018579:Patient Selection; D011725:Pyridines / Q000008:administration & dosage* / Q000493:pharmacokinetics; D000069552:Rivaroxaban; D013876:Thiophenes / Q000008:administration & dosage* / Q000493:pharmacokinetics; D054556:Venous Thromboembolism / Q000517:prevention & control*
D000925:Anticoagulants; D001562:Benzimidazoles; D009025:Morpholines; D011725:Pyridines; D013876:Thiophenes; D000069552:Rivaroxaban; D000069604:Dabigatran